---
figid: PMC10526140__biomolecules-13-01296-g004
pmcid: PMC10526140
image_filename: biomolecules-13-01296-g004.jpg
figure_link: /pmc/articles/PMC10526140/figure/biomolecules-13-01296-f004/
number: Figure 4
figure_title: ''
caption: The diagram portrays the comprehensive signalling model involving tumour
  suppressors like p53 and BRCA1. It visually represents how various molecules, well-established
  for their roles in influencing cell proliferation, DNA damage response and cell
  cycle control interact within the regulatory pathway.
article_title: Understanding the Clinical Use of Levosimendan and Perspectives on
  its Future in Oncology.
citation: Eduarda Ribeiro, et al. Biomolecules. 2023 Sep;13(9):1296.
year: '2023'

doi: 10.3390/biom13091296
journal_title: Biomolecules
journal_nlm_ta: Biomolecules
publisher_name: MDPI

keywords:
- levosimendan
- cancer
- drug repurposing
- drug combinations
- vasodilatory mechanisms

---
